Geographically-weighted regression of knowledge and behaviour determinants to anti-malarial recommending and dispensing practice among medicine retailers in western Kenya: capacitating targeted interventions

Table 2 Association between medicine retailer knowledge, behaviours and study outcomes

	% (n)	Unadjusted odds ratios and (95% confidence intervals; p-values)
	% (n)	Recommended ACTs as malaria treatment for adult patients	Recommended ACTs as malaria treatment for under 5 patients	Reported selling ACTs more than any other antimalarial
Identified ACT as MOH-recommended antimalarial
No	37% (32)	1 (reference)	1 (reference)	1 (reference)
Yes	63% (55)	3.0 (1.21–7.47; 0.018)**	2.34 (0.93–5.88; 0.070)*	2.36 (0.92–6.03; 0.073)*
Recommended ACT to adults
No	45% (39)	–	1 (reference)	1 (reference)
Yes	55% (48)	–	5.37 (2.08–13.87; 0.001)**	8.89 (3.11–25.39; < 0.001)**
Recommended ACT to children
No	55% (48)	1 (reference)	–	1 (reference)
Yes	45% (39)	5.37 (2.08–13.87; 0.001)**	–	3.76 (1.52–9.28; 0.004)**
Sold ACTs more than any other antimalarial
No	59% (51)	1 (reference)	1 (reference)	–
Yes	41% (36)	8.89 (3.11–25.39; < 0.001)**	3.76 (1.52–9.28; 0.004)**	–
Gave Fansidar to a mother requesting it
No	81% (70)	1 (reference)	1 (reference)	1 (reference)
Yes	18% (16)	0.67 (0.21–2.01; 0.461)	0.36 (0.11–1.25; 0.109)*	0.94 (0.30–2.94; 0.919)

ISSN: 1475-2875